Department of Biological Sciences and Bioengineering, Indian Institute of Technology Kanpur, Kanpur 208016, India.
Biomater Sci. 2020 Mar 31;8(7):1996-2006. doi: 10.1039/c9bm01978b.
Recently, fluorenylmethyloxycarbonyl (Fmoc) conjugated amino acids (Fmoc-AA), especially Fmoc-phenylalanine (Fmoc-F), have been discovered to have antimicrobial properties specific to Gram-positive bacteria including MRSA. Their weak antibacterial activity against Gram-negative bacteria is due to their inability to cross the bacterial membrane. Here in order to increase the antibacterial spectrum of Fmoc-F, we prepared a formulation of Fmoc-F with the Gram-negative specific antibiotic aztreonam (AZT). This formulation displayed antibacterial activity against both Gram-positive and Gram-negative bacteria and significantly reduced the bacterial load in a mouse wound infection model. The combination produced a synergistic effect and higher efficacy against P. aeruginosa due to the increased Fmoc-F permeability by AZT through the bacterial membrane. This combinatorial approach could be an effective strategy for other Fmoc-AA having a Gram-positive specific antibacterial effect for the better management of bacterial wound infections.
最近,芴甲氧羰基(Fmoc)缀合氨基酸(Fmoc-AA),特别是 Fmoc-苯丙氨酸(Fmoc-F),已被发现对包括耐甲氧西林金黄色葡萄球菌(MRSA)在内的革兰氏阳性菌具有特定的抗菌特性。它们对革兰氏阴性菌的抗菌活性较弱,是因为它们无法穿过细菌膜。在这里,为了增加 Fmoc-F 的抗菌谱,我们用革兰氏阴性特异性抗生素氨曲南(AZT)制备了 Fmoc-F 的制剂。该制剂对革兰氏阳性和革兰氏阴性细菌均显示出抗菌活性,并显著降低了小鼠伤口感染模型中的细菌负荷。由于 AZT 通过细菌膜增加了 Fmoc-F 的通透性,该组合产生了协同作用,并对铜绿假单胞菌具有更高的疗效。对于其他具有革兰氏阳性特异性抗菌作用的 Fmoc-AA 来说,这种组合方法可能是一种有效的策略,可更好地管理细菌伤口感染。